- Emyria has a green light to commence a ground-breaking trial on MDMA-assisted therapy for Post-Traumatic Stress Disorder (PTSD)!
- Emyria is leveraging its unique partnership with the PAX Centre, Australia's leading trauma-focused psychiatric service
- Emyria's collaborative relationship with PAX distinguishes Emyria as the sole group in Australia partnered with a comprehensive, trauma-focused multidisciplinary psychiatric service
- Emyria advocates that psychedelic-assisted therapies should be provided within comprehensive mental health services - like PAX - to ensure maximum patient safety
- Emyria & PAX now is uniquely positioned in Australia with its combination of trained therapists, reliable drug supply, an active community-based psychiatrist service, Real-World Data capture expertise and now, an ethics-approved protocol
- Emyria is greatly expanding treatment options for patients with PTSD advancing Emyria's aims to become the leading provider, and developer, of innovative therapies for challenging mental health conditions
- Forums
- ASX - By Stock
- general talk
Emyria has a green light to commence a ground-breaking trial on...
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
4.5¢ |
Change
-0.002(3.26%) |
Mkt cap ! $18.20M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.5¢ | $21.39K | 460.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 269585 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.043 |
1 | 3800 | 0.042 |
5 | 134100 | 0.040 |
3 | 224359 | 0.039 |
3 | 533445 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 188791 | 2 |
0.050 | 290009 | 5 |
0.051 | 10000 | 1 |
0.055 | 150000 | 2 |
0.059 | 131956 | 3 |
Last trade - 15.33pm 06/09/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |